...
机译:寄生虫膜联蛋白–具有开发药物和疫苗潜力的新分子
Structural Chemistry Program, Eskitis Institute for Cell and Molecular Therapies, Griffith University, Nathan, Queensland, Australia;
Structural Chemistry Program, Eskitis Institute for Cell and Molecular Therapies, Griffith University, Nathan, Queensland, Australia;
Queensland Institute of Medical Research, Herston, Queensland, Australia|School of Veterinary Sciences, University of Queensland, Queensland, Australia|Institute for Research in Molecular Medicine, Universiti Sains Malaysia, Penang, Malaysia;
Queensland Institute of Medical Research, Herston, Queensland, Australia;
Queensland Institute of Medical Research, Herston, Queensland, Australia;
Queensland Institute of Medical Research, Herston, Queensland, Australia|School of Veterinary Sciences, University of Queensland, Queensland, Australia;
annexins; drug discovery; helminths; infectious diseases; nematodes; parasites; vaccine design;
机译:寄生虫膜联蛋白-具有开发药物和疫苗潜力的新分子。
机译:金(I)膦化合物作为寄生虫衰减剂用于疟疾疫苗和药物发育
机译:牛ApiCoMplexan寄生虫的比较转录组织Hiteria PARVA发育阶段揭示了巨大的基因表达变异和潜在疫苗抗原
机译:快速生产用于药物和疫苗开发的伪型VLPS昆虫细胞平台的开发
机译:探究疟疾寄生虫恶性疟原虫的翻译调控:应用新型体外测定方法来鉴定调控的遗传决定因素并鉴定利用恶性疟原虫翻译作为药物靶点的小分子
机译:牛ApiCoMplexan寄生虫的比较转录组织Hiteria PARVA发育阶段揭示了巨大的基因表达变异和潜在疫苗抗原
机译:寄生虫膜联蛋白-具有开发药物和疫苗潜力的新分子
机译:人类疟疾寄生虫间日疟原虫肝脏阶段的蛋白质组学研究用于疫苗和药物的开发